Aerpio Therapeutics

1 follower


Aerpio Therapeutics, abiotechnology company,develops new small molecules and monoclonal antibodies for the treatment of vascular disease.

Industries

Headquarters

Stage

Employees

Links

Joseph Gardner
President and Founder

Joseph Gardner

Collapse
Barb Withers
VP, Clinical Operations
Brandi Soldo
Vice-President, Toxicology
Chris Ernst
VP, CMC and Quality Assurance
Gina Marek
Vice-President, Finance
Kevin Peters
Chief Scientific Officer
Mitchell Brigell
Consultant, VP Clinical